1 Study Coverage 1.1 Allergic Conjunctivitis Drug Product Introduction 1.2 Global Allergic Conjunctivitis Drug Outlook 2017 VS 2022 VS 2028 1.2.1 Global Allergic Conjunctivitis Drug Sales in US$ Million for the Year 2017-2028 1.2.2 Global Allergic Conjunctivitis Drug Sales in Volume for the Year 2017-2028 1.3 United States Allergic Conjunctivitis Drug Outlook 2017 VS 2022 VS 2028 1.3.1 United States Allergic Conjunctivitis Drug Sales in US$ Million for the Year 2017-2028 1.3.2 United States Allergic Conjunctivitis Drug Sales in Volume for the Year 2017-2028 1.4 Allergic Conjunctivitis Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Allergic Conjunctivitis Drug in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Allergic Conjunctivitis Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Allergic Conjunctivitis Drug Market Dynamics 1.5.1 Allergic Conjunctivitis Drug Industry Trends 1.5.2 Allergic Conjunctivitis Drug Market Drivers 1.5.3 Allergic Conjunctivitis Drug Market Challenges 1.5.4 Allergic Conjunctivitis Drug Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Allergic Conjunctivitis Drug Market Segment by Type 2.1.1 CPC-888 2.1.2 CVXL-0074 2.1.3 ADX-102 2.1.4 AGN-229666 2.1.5 Dexamethasone Acetate SR 2.1.6 Others 2.2 Global Allergic Conjunctivitis Drug Market Size by Type 2.2.1 Global Allergic Conjunctivitis Drug Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Allergic Conjunctivitis Drug Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Allergic Conjunctivitis Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Allergic Conjunctivitis Drug Market Size by Type 2.3.1 United States Allergic Conjunctivitis Drug Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Allergic Conjunctivitis Drug Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Allergic Conjunctivitis Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Allergic Conjunctivitis Drug Market Segment by Application 3.1.1 Clinic 3.1.2 Research Center 3.1.3 Hospital 3.1.4 Others 3.2 Global Allergic Conjunctivitis Drug Market Size by Application 3.2.1 Global Allergic Conjunctivitis Drug Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Allergic Conjunctivitis Drug Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Allergic Conjunctivitis Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Allergic Conjunctivitis Drug Market Size by Application 3.3.1 United States Allergic Conjunctivitis Drug Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Allergic Conjunctivitis Drug Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Allergic Conjunctivitis Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Allergic Conjunctivitis Drug Competitor Landscape by Company 4.1 Global Allergic Conjunctivitis Drug Market Size by Company 4.1.1 Top Global Allergic Conjunctivitis Drug Manufacturers Ranked by Revenue (2021) 4.1.2 Global Allergic Conjunctivitis Drug Revenue by Manufacturer (2017-2022) 4.1.3 Global Allergic Conjunctivitis Drug Sales by Manufacturer (2017-2022) 4.1.4 Global Allergic Conjunctivitis Drug Price by Manufacturer (2017-2022) 4.2 Global Allergic Conjunctivitis Drug Concentration Ratio (CR) 4.2.1 Allergic Conjunctivitis Drug Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Allergic Conjunctivitis Drug in 2021 4.2.3 Global Allergic Conjunctivitis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Allergic Conjunctivitis Drug Manufacturing Base Distribution, Product Type 4.3.1 Global Allergic Conjunctivitis Drug Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Allergic Conjunctivitis Drug Product Type 4.3.3 Date of International Manufacturers Enter into Allergic Conjunctivitis Drug Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Allergic Conjunctivitis Drug Market Size by Company 4.5.1 Top Allergic Conjunctivitis Drug Players in United States, Ranked by Revenue (2021) 4.5.2 United States Allergic Conjunctivitis Drug Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Allergic Conjunctivitis Drug Sales by Players (2020, 2021 & 2022) 5 Global Allergic Conjunctivitis Drug Market Size by Region 5.1 Global Allergic Conjunctivitis Drug Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Allergic Conjunctivitis Drug Market Size in Volume by Region (2017-2028) 5.2.1 Global Allergic Conjunctivitis Drug Sales in Volume by Region: 2017-2022 5.2.2 Global Allergic Conjunctivitis Drug Sales in Volume Forecast by Region (2023-2028) 5.3 Global Allergic Conjunctivitis Drug Market Size in Value by Region (2017-2028) 5.3.1 Global Allergic Conjunctivitis Drug Sales in Value by Region: 2017-2022 5.3.2 Global Allergic Conjunctivitis Drug Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Allergic Conjunctivitis Drug Market Size YoY Growth 2017-2028 6.1.2 North America Allergic Conjunctivitis Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Allergic Conjunctivitis Drug Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Allergic Conjunctivitis Drug Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Allergic Conjunctivitis Drug Market Size YoY Growth 2017-2028 6.3.2 Europe Allergic Conjunctivitis Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Allergic Conjunctivitis Drug Market Size YoY Growth 2017-2028 6.4.2 Latin America Allergic Conjunctivitis Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Allergic Conjunctivitis Drug Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Allergic Conjunctivitis Drug Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 UAE 7 Company Profiles 7.1 Accolade Pharmaceuticals LLC 7.1.1 Accolade Pharmaceuticals LLC Corporation Information 7.1.2 Accolade Pharmaceuticals LLC Description and Business Overview 7.1.3 Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Products Offered 7.1.5 Accolade Pharmaceuticals LLC Recent Development 7.2 Aldeyra Therapeutics Inc 7.2.1 Aldeyra Therapeutics Inc Corporation Information 7.2.2 Aldeyra Therapeutics Inc Description and Business Overview 7.2.3 Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Products Offered 7.2.5 Aldeyra Therapeutics Inc Recent Development 7.3 AlleCures Inc 7.3.1 AlleCures Inc Corporation Information 7.3.2 AlleCures Inc Description and Business Overview 7.3.3 AlleCures Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.3.4 AlleCures Inc Allergic Conjunctivitis Drug Products Offered 7.3.5 AlleCures Inc Recent Development 7.4 Allergan Plc 7.4.1 Allergan Plc Corporation Information 7.4.2 Allergan Plc Description and Business Overview 7.4.3 Allergan Plc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Allergan Plc Allergic Conjunctivitis Drug Products Offered 7.4.5 Allergan Plc Recent Development 7.5 Clevexel Pharma SAS 7.5.1 Clevexel Pharma SAS Corporation Information 7.5.2 Clevexel Pharma SAS Description and Business Overview 7.5.3 Clevexel Pharma SAS Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Clevexel Pharma SAS Allergic Conjunctivitis Drug Products Offered 7.5.5 Clevexel Pharma SAS Recent Development 7.6 Griffin Discoveries BV 7.6.1 Griffin Discoveries BV Corporation Information 7.6.2 Griffin Discoveries BV Description and Business Overview 7.6.3 Griffin Discoveries BV Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Griffin Discoveries BV Allergic Conjunctivitis Drug Products Offered 7.6.5 Griffin Discoveries BV Recent Development 7.7 Ocular Therapeutix Inc 7.7.1 Ocular Therapeutix Inc Corporation Information 7.7.2 Ocular Therapeutix Inc Description and Business Overview 7.7.3 Ocular Therapeutix Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Ocular Therapeutix Inc Allergic Conjunctivitis Drug Products Offered 7.7.5 Ocular Therapeutix Inc Recent Development 7.8 Ohr Pharmaceutical Inc 7.8.1 Ohr Pharmaceutical Inc Corporation Information 7.8.2 Ohr Pharmaceutical Inc Description and Business Overview 7.8.3 Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.8.4 Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Products Offered 7.8.5 Ohr Pharmaceutical Inc Recent Development 7.9 Portola Pharmaceuticals Inc 7.9.1 Portola Pharmaceuticals Inc Corporation Information 7.9.2 Portola Pharmaceuticals Inc Description and Business Overview 7.9.3 Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.9.4 Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Products Offered 7.9.5 Portola Pharmaceuticals Inc Recent Development 7.10 Re-Pharm Ltd 7.10.1 Re-Pharm Ltd Corporation Information 7.10.2 Re-Pharm Ltd Description and Business Overview 7.10.3 Re-Pharm Ltd Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.10.4 Re-Pharm Ltd Allergic Conjunctivitis Drug Products Offered 7.10.5 Re-Pharm Ltd Recent Development 7.11 Realm Therapeutics Plc 7.11.1 Realm Therapeutics Plc Corporation Information 7.11.2 Realm Therapeutics Plc Description and Business Overview 7.11.3 Realm Therapeutics Plc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.11.4 Realm Therapeutics Plc Allergic Conjunctivitis Drug Products Offered 7.11.5 Realm Therapeutics Plc Recent Development 7.12 Sylentis SAU 7.12.1 Sylentis SAU Corporation Information 7.12.2 Sylentis SAU Description and Business Overview 7.12.3 Sylentis SAU Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.12.4 Sylentis SAU Products Offered 7.12.5 Sylentis SAU Recent Development 7.13 Xencor Inc 7.13.1 Xencor Inc Corporation Information 7.13.2 Xencor Inc Description and Business Overview 7.13.3 Xencor Inc Allergic Conjunctivitis Drug Sales, Revenue and Gross Margin (2017-2022) 7.13.4 Xencor Inc Products Offered 7.13.5 Xencor Inc Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Allergic Conjunctivitis Drug Industry Chain Analysis 8.2 Allergic Conjunctivitis Drug Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Allergic Conjunctivitis Drug Distributors 8.3 Allergic Conjunctivitis Drug Production Mode & Process 8.4 Allergic Conjunctivitis Drug Sales and Marketing 8.4.1 Allergic Conjunctivitis Drug Sales Channels 8.4.2 Allergic Conjunctivitis Drug Distributors 8.5 Allergic Conjunctivitis Drug Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Allergic Conjunctivitis Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Allergic Conjunctivitis Drug Market Trends Table 3. Allergic Conjunctivitis Drug Market Drivers Table 4. Allergic Conjunctivitis Drug Market Challenges Table 5. Allergic Conjunctivitis Drug Market Restraints Table 6. Global Allergic Conjunctivitis Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Allergic Conjunctivitis Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Allergic Conjunctivitis Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Allergic Conjunctivitis Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Allergic Conjunctivitis Drug Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Allergic Conjunctivitis Drug Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Allergic Conjunctivitis Drug Revenue Share by Manufacturer, 2017-2022 Table 13. Global Allergic Conjunctivitis Drug Sales by Manufacturer, (K Pcs), 2017-2022 Table 14. Global Allergic Conjunctivitis Drug Sales Share by Manufacturer, 2017-2022 Table 15. Global Allergic Conjunctivitis Drug Price by Manufacturer (2017-2022) & (USD/Pcs) Table 16. Global Allergic Conjunctivitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Allergic Conjunctivitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergic Conjunctivitis Drug as of 2021) Table 18. Top Players of Allergic Conjunctivitis Drug in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Allergic Conjunctivitis Drug Product Type Table 20. Date of International Manufacturers Enter into Allergic Conjunctivitis Drug Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Allergic Conjunctivitis Drug Players in United States Market, Ranking by Revenue (2021) Table 23. United States Allergic Conjunctivitis Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Allergic Conjunctivitis Drug Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Allergic Conjunctivitis Drug Sales by Players, (K Pcs), 2020, 2021 & 2022 Table 26. United States Allergic Conjunctivitis Drug Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Allergic Conjunctivitis Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Allergic Conjunctivitis Drug Sales in Volume by Region (2017-2022) & (K Pcs) Table 29. Global Allergic Conjunctivitis Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs) Table 30. Global Allergic Conjunctivitis Drug Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Allergic Conjunctivitis Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Allergic Conjunctivitis Drug Sales in Volume by Country (2017-2028) & (K Pcs) Table 33. North America Allergic Conjunctivitis Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Allergic Conjunctivitis Drug Sales in Volume by Region (2017-2028) & (K Pcs) Table 35. Asia Pacific Allergic Conjunctivitis Drug Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Allergic Conjunctivitis Drug Sales in Volume by Country (2017-2028) & (K Pcs) Table 37. Europe Allergic Conjunctivitis Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Allergic Conjunctivitis Drug Sales in Volume by Country (2017-2028) & (K Pcs) Table 39. Latin Americaa Allergic Conjunctivitis Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Allergic Conjunctivitis Drug Sales in Volume by Country (2017-2028) & (K Pcs) Table 41. Middle East and Africa Allergic Conjunctivitis Drug Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Accolade Pharmaceuticals LLC Corporation Information Table 43. Accolade Pharmaceuticals LLC Description and Business Overview Table 44. Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 45. Accolade Pharmaceuticals LLC Allergic Conjunctivitis Drug Product Table 46. Accolade Pharmaceuticals LLC Recent Development Table 47. Aldeyra Therapeutics Inc Corporation Information Table 48. Aldeyra Therapeutics Inc Description and Business Overview Table 49. Aldeyra Therapeutics Inc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 50. Aldeyra Therapeutics Inc Product Table 51. Aldeyra Therapeutics Inc Recent Development Table 52. AlleCures Inc Corporation Information Table 53. AlleCures Inc Description and Business Overview Table 54. AlleCures Inc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 55. AlleCures Inc Product Table 56. AlleCures Inc Recent Development Table 57. Allergan Plc Corporation Information Table 58. Allergan Plc Description and Business Overview Table 59. Allergan Plc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 60. Allergan Plc Product Table 61. Allergan Plc Recent Development Table 62. Clevexel Pharma SAS Corporation Information Table 63. Clevexel Pharma SAS Description and Business Overview Table 64. Clevexel Pharma SAS Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 65. Clevexel Pharma SAS Product Table 66. Clevexel Pharma SAS Recent Development Table 67. Griffin Discoveries BV Corporation Information Table 68. Griffin Discoveries BV Description and Business Overview Table 69. Griffin Discoveries BV Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 70. Griffin Discoveries BV Product Table 71. Griffin Discoveries BV Recent Development Table 72. Ocular Therapeutix Inc Corporation Information Table 73. Ocular Therapeutix Inc Description and Business Overview Table 74. Ocular Therapeutix Inc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 75. Ocular Therapeutix Inc Product Table 76. Ocular Therapeutix Inc Recent Development Table 77. Ohr Pharmaceutical Inc Corporation Information Table 78. Ohr Pharmaceutical Inc Description and Business Overview Table 79. Ohr Pharmaceutical Inc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 80. Ohr Pharmaceutical Inc Product Table 81. Ohr Pharmaceutical Inc Recent Development Table 82. Portola Pharmaceuticals Inc Corporation Information Table 83. Portola Pharmaceuticals Inc Description and Business Overview Table 84. Portola Pharmaceuticals Inc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 85. Portola Pharmaceuticals Inc Product Table 86. Portola Pharmaceuticals Inc Recent Development Table 87. Re-Pharm Ltd Corporation Information Table 88. Re-Pharm Ltd Description and Business Overview Table 89. Re-Pharm Ltd Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 90. Re-Pharm Ltd Product Table 91. Re-Pharm Ltd Recent Development Table 92. Realm Therapeutics Plc Corporation Information Table 93. Realm Therapeutics Plc Description and Business Overview Table 94. Realm Therapeutics Plc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 95. Realm Therapeutics Plc Product Table 96. Realm Therapeutics Plc Recent Development Table 97. Sylentis SAU Corporation Information Table 98. Sylentis SAU Description and Business Overview Table 99. Sylentis SAU Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 100. Sylentis SAU Product Table 101. Sylentis SAU Recent Development Table 102. Xencor Inc Corporation Information Table 103. Xencor Inc Description and Business Overview Table 104. Xencor Inc Allergic Conjunctivitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 105. Xencor Inc Product Table 106. Xencor Inc Recent Development Table 107. Key Raw Materials Lists Table 108. Raw Materials Key Suppliers Lists Table 109. Allergic Conjunctivitis Drug Customers List Table 110. Allergic Conjunctivitis Drug Distributors List Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Allergic Conjunctivitis Drug Product Picture Figure 2. Global Allergic Conjunctivitis Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Allergic Conjunctivitis Drug Market Size 2017-2028 (US$ Million) Figure 4. Global Allergic Conjunctivitis Drug Sales 2017-2028 (K Pcs) Figure 5. United States Allergic Conjunctivitis Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Allergic Conjunctivitis Drug Market Size 2017-2028 (US$ Million) Figure 7. United States Allergic Conjunctivitis Drug Sales 2017-2028 (K Pcs) Figure 8. United States Allergic Conjunctivitis Drug Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Allergic Conjunctivitis Drug Market Share in Global, in Volume (K Pcs) 2017-2028 Figure 10. Allergic Conjunctivitis Drug Report Years Considered Figure 11. Product Picture of CPC-888 Figure 12. Product Picture of CVXL-0074 Figure 13. Product Picture of ADX-102 Figure 14. Product Picture of AGN-229666 Figure 15. Product Picture of Dexamethasone Acetate SR Figure 16. Product Picture of Others Figure 17. Global Allergic Conjunctivitis Drug Market Share by Type in 2022 & 2028 Figure 18. Global Allergic Conjunctivitis Drug Sales in Value by Type (2017-2028) & (US$ Million) Figure 19. Global Allergic Conjunctivitis Drug Sales Market Share in Value by Type (2017-2028) Figure 20. Global Allergic Conjunctivitis Drug Sales by Type (2017-2028) & (K Pcs) Figure 21. Global Allergic Conjunctivitis Drug Sales Market Share in Volume by Type (2017-2028) Figure 22. Global Allergic Conjunctivitis Drug Price by Type (2017-2028) & (USD/Pcs) Figure 23. United States Allergic Conjunctivitis Drug Market Share by Type in 2022 & 2028 Figure 24. United States Allergic Conjunctivitis Drug Sales in Value by Type (2017-2028) & (US$ Million) Figure 25. United States Allergic Conjunctivitis Drug Sales Market Share in Value by Type (2017-2028) Figure 26. United States Allergic Conjunctivitis Drug Sales by Type (2017-2028) & (K Pcs) Figure 27. United States Allergic Conjunctivitis Drug Sales Market Share in Volume by Type (2017-2028) Figure 28. United States Allergic Conjunctivitis Drug Price by Type (2017-2028) & (USD/Pcs) Figure 29. Product Picture of Clinic Figure 30. Product Picture of Research Center Figure 31. Product Picture of Hospital Figure 32. Product Picture of Others Figure 33. Global Allergic Conjunctivitis Drug Market Share by Application in 2022 & 2028 Figure 34. Global Allergic Conjunctivitis Drug Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. Global Allergic Conjunctivitis Drug Sales Market Share in Value by Application (2017-2028) Figure 36. Global Allergic Conjunctivitis Drug Sales by Application (2017-2028) & (K Pcs) Figure 37. Global Allergic Conjunctivitis Drug Sales Market Share in Volume by Application (2017-2028) Figure 38. Global Allergic Conjunctivitis Drug Price by Application (2017-2028) & (USD/Pcs) Figure 39. United States Allergic Conjunctivitis Drug Market Share by Application in 2022 & 2028 Figure 40. United States Allergic Conjunctivitis Drug Sales in Value by Application (2017-2028) & (US$ Million) Figure 41. United States Allergic Conjunctivitis Drug Sales Market Share in Value by Application (2017-2028) Figure 42. United States Allergic Conjunctivitis Drug Sales by Application (2017-2028) & (K Pcs) Figure 43. United States Allergic Conjunctivitis Drug Sales Market Share in Volume by Application (2017-2028) Figure 44. United States Allergic Conjunctivitis Drug Price by Application (2017-2028) & (USD/Pcs) Figure 45. North America Allergic Conjunctivitis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 46. North America Allergic Conjunctivitis Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. U.S. Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Canada Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Europe Allergic Conjunctivitis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 50. Europe Allergic Conjunctivitis Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 51. Germany Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. France Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. U.K. Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Italy Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Russia Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Asia-Pacific Allergic Conjunctivitis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 57. Asia-Pacific Allergic Conjunctivitis Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 58. China Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Japan Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. South Korea Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. India Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Australia Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Taiwan Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Indonesia Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Thailand Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Malaysia Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Philippines Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Latin America Allergic Conjunctivitis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 69. Latin America Allergic Conjunctivitis Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Mexico Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Brazil Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Argentina Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Middle East & Africa Allergic Conjunctivitis Drug Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 74. Middle East & Africa Allergic Conjunctivitis Drug Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 75. Turkey Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Saudi Arabia Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 77. UAE Allergic Conjunctivitis Drug Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 78. Allergic Conjunctivitis Drug Value Chain Figure 79. Allergic Conjunctivitis Drug Production Process Figure 80. Channels of Distribution Figure 81. Distributors Profiles Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed

Accolade Pharmaceuticals LLC Aldeyra Therapeutics Inc AlleCures Inc Allergan Plc Clevexel Pharma SAS Griffin Discoveries BV Ocular Therapeutix Inc Ohr Pharmaceutical Inc Portola Pharmaceuticals Inc Re-Pharm Ltd Realm Therapeutics Plc Sylentis SAU Xencor Inc